ArticleFrontiers in immunology2021

TNF-Alpha Pathway Alternation Predicts Survival of Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer.

Anqi Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.